Clinical trial
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular…
NCT00460408 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00460408 |
|---|---|
| Title | Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration |
| Official title | European Epidemiologic COHORT Study: A Prospective Epidemiologic COHORT Study Of Ocular Safety In Patients Receiving Macugen Injections For Neovascular Age-Related Macular Degeneration (AMD) In Europe |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | Macugen |
| Enrollment | 501 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Apr 16, 2007 |
| Last update posted | Dec 11, 2012 |
| Countries | Belgium, Cyprus, Czechia, Denmark, France, Germany, Greece, Ireland, Italy, Poland, Slovakia, Spain and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: